Display options
Share it on

Joints. 2015 Nov 03;3(2):85-90. doi: 10.11138/jts/2015.3.2.085. eCollection 2015.

Anterior cruciate ligament reconstruction with a novel porcine xenograft: the initial Italian experience.

Joints

Stefano Zaffagnini, Alberto Grassi, Giulio Maria Marcheggiani Muccioli, Tommaso Roberti Di Sarsina, Federico Raggi, Andrea Benzi, Maurilio Marcacci

Affiliations

  1. The II Orthopaedic and Traumatology Clinic, Biomechanics Laboratory and Technological Innovation, Rizzoli Orthopaedic Institute, Bologna, Italy.

PMID: 26605257 PMCID: PMC4634810 DOI: 10.11138/jts/2015.3.2.085

Abstract

At the current state of the art in anterior cruciate ligament (ACL) reconstruction, multiple techniques have been presented but none has given clearly defined and improved results. One of the main issues concerns the choice of graft. The concept of using xenograft tissue, defined as a graft tissue from one species and destined for implantation in an unlike species, was introduced in order to try to overcome the mechanical and biological concerns associated with synthetic materials and the safety and quality concerns and availability problems of allograft tissue. Xenograft tissue carries the risk of producing an immunological reaction. In order to try to overcome or attenuate the immune response against porcine xenograft tissue, the Z-Process® (Aperion Biologics Inc, San Antonio, Texas, USA) has been developed and used to produce the Z-Lig® family of devices for ACL reconstruction procedures. Z-Lig® is a tendon graft with or without bone blocks, sourced from animal tissue in a manner consistent with what has normally been sourced from human tissue, and processed to overcome anti-Gal-mediated rejection and to attenuate other immunological recognition in humans. All this while ensuring sterility, viral inactivation and preservation of mechanical proprieties appropriate for an ACL reconstruction device. The Z-Lig® device has been tested in skeletally mature monkeys and given interesting and promising results from the preclinical performance and safety profile point of view. On this basis, it was possible to proceed with the first clinical trial involving humans, which gave similar encouraging results. The Z-Lig® device has also been implanted in Italy at the Rizzoli Orthopaedic Institute in Bologna, as a part of international multicenter prospective randomized blinded controlled study aimed at comparing xenograft with allograft tissue.

Keywords: Z-Lig; anterior cruciate ligament; knee; reconstruction; xenograft

References

  1. J Biomed Mater Res. 1996 Jul;31(3):319-28 - PubMed
  2. Science. 2002 Feb 8;295(5557):1089-92 - PubMed
  3. Science. 2003 Jan 17;299(5605):411-4 - PubMed
  4. J Bone Joint Surg Br. 1992 Jul;74(4):617-9 - PubMed
  5. Arthroscopy. 2007 Apr;23(4):411-9 - PubMed
  6. Transplantation. 2007 Jan 27;83(2):211-9 - PubMed
  7. Nat Med. 2005 Jan;11(1):32-4 - PubMed
  8. J Orthop Res. 1989;7(6):910-21 - PubMed
  9. Clin Orthop Relat Res. 1991 Jun;(267):278-93 - PubMed
  10. Xenotransplantation. 2003 Jan;10(1):88-93 - PubMed
  11. Clin Orthop Relat Res. 1985 Jun;(196):77-85 - PubMed
  12. Clin Orthop Relat Res. 1985 Jun;(196):202-13 - PubMed
  13. Nat Med. 2005 Jan;11(1):29-31 - PubMed
  14. Knee Surg Sports Traumatol Arthrosc. 1994;2(4):219-23 - PubMed
  15. Transplantation. 1998 Jun 27;65(12):1577-83 - PubMed
  16. Immunol Today. 1993 Oct;14(10):480-2 - PubMed
  17. Am J Sports Med. 1989 May-Jun;17(3):380-5; discussion 385-6 - PubMed
  18. Transplantation. 1997 Mar 15;63(5):646-51 - PubMed

Publication Types